Drug Type Gene therapy |
Synonyms Lysine Demethylase 4D (StemCardia) |
Target |
Action modulators |
Mechanism KDM4D modulators(lysine demethylase 4D modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic heart failure | Discovery | United States | 01 Nov 2024 |